Jemperli 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DX25F6TYZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $29,808
Award facts
- Contract value 100% obligated
- $29,807.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On August 27, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for JEMPERLI 500 mg/10 mL vials with a ceiling value of approximately $29.8K. JEMPERLI (venetoclax) is a targeted cancer therapy used in hematologic malignancies, and this order reflects the federal government's procurement of specialized pharmaceutical products to support military and veteran healthcare systems. The delivery order is structured as a firm fixed-price contract with no set-aside designation, indicating competitive award based on capability demonstration. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 18, 2025.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs worldwide. AmerisourceBergen maintains a significant role as a federal pharmaceutical distributor, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive contract vehicles. The DLA Troop Support is planning future Pharmaceutical Prime Vendor Global Program Generation V contracts with potential multiple awards across regions, positioning AmerisourceBergen among critical vendors for federal medical procurement.
Quick answers
Who was awarded contract SPE2DX25F6TYZ?
SPE2DX25F6TYZ was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 27, 2025.
How much is contract SPE2DX25F6TYZ worth?
The government has obligated $29,808 on SPE2DX25F6TYZ.
Is contract SPE2DX25F6TYZ an order under another contract?
Yes. SPE2DX25F6TYZ is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6TYZ competed?
The extent of competition for SPE2DX25F6TYZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award